All Times EDT
Legend:
Activity Details
116 * !
Mon, 8/3/2020,
1:00 PM -
2:50 PM
Virtual
Everyone Counts in ASA: An Informational Walk Through the Organization, Activities, and Opportunities — Invited Panel
Committee on Applied Statisticians
Organizer(s): Allison Monsees Florance, Novartis
Chair(s): Allison Monsees Florance, Novartis
1:05 PM
Everyone Counts in ASA – an Informational Walk Through the Organization, Activities and Opportunities
Panelists:
Katherine L Monti, Retired Richard C Zink, TARGET PharmaSolutions Inc Richard Levine, San Diego State University Christian Léger, Université de Montréal Dionne Swift, Procter and Gamble Sameera Wijayawardana, Eli Lilly Donna LaLonde, American Statistical Association
2:40 PM
Floor Discussion
157 * !
Tue, 8/4/2020,
10:00 AM -
11:50 AM
Virtual
Translational Statistics: Problems in Preclinical Studies and a Call for Change — Topic Contributed Papers
Section on Teaching of Statistics in the Health Sciences , Biopharmaceutical Section, Committee on Applied Statisticians
Organizer(s): Penny Reynolds, University of Florida School of Medicine
Chair(s): Sujata M Patil, Memorial Sloan Kettering Cancer Center
10:05 AM
Non-Informative Preclinical Research: What Statisticians Need to Know.
Penny Reynolds, University of Florida School of Medicine
10:25 AM
Common Problems in the Design of Preclinical Animal Experiments
Presentation
Stanley Lazic, Prioris.ai Inc.
10:45 AM
Statistical Reporting Must Improve in Preclinical Research
Presentation
Romain-Daniel Gosselin, Lausanne University Hospital (CHUV)
11:05 AM
Discussant: Cynthia W Garvan, University of Florida School of Medicine
11:25 AM
Discussant: Nancy Flournoy, University of Missouri-Columbia
11:45 AM
Floor Discussion
167 *
Tue, 8/4/2020,
10:00 AM -
11:50 AM
Virtual
Sports Analytics Outside the Big Four — Topic Contributed Papers
Section on Statistics in Sports , Committee on Women in Statistics, Committee on Applied Statisticians
Organizer(s): Monnie McGee, Southern Methodist University
Chair(s): Michael Rutter, Penn State Erie, The Behrend College
10:05 AM
The Optimal Value Bill James’ Pythagorean Method for the National Lacrosse League
James Cochran, University of Alabama ; Hayden Howell, Georgia Tech
10:25 AM
Do Female High School Athletes Peak Earlier Than Males? a Time Course Analysis of Times for Various Track and Field Events
Monnie McGee, Southern Methodist University ; Jacy Sparks, Southern Methodist University
10:45 AM
Injuries in Female Wrestlers Presenting to the Emergency Department in the United States
Malik Outram, Virginia Tech ; Heather Pieno, Virginia Tech; Mariam Farzayee, Virginia Tech; Medina Etemadi, Virginia Tech; Sam Miller, Virginia Tech; Charlotte Baker, Virginia Tech
11:05 AM
Fair Qualifying Times Across Age and Gender Categories for the Boston Marathon
Richard Smith, University of North Carolina at Chapel Hill
11:25 AM
Floor Discussion
293 * !
Wed, 8/5/2020,
10:00 AM -
11:50 AM
Virtual
Advances in the Analysis of Competing and Semi-Competing Risks Data in Medical Research — Invited Papers
Biometrics Section , Committee on Applied Statisticians, Statistical and Applied Mathematical Sciences Institute, Lifetime Data Science Section
Organizer(s): Sujata M Patil, Memorial Sloan Kettering Cancer Center
Chair(s): Jaya Satagopan, Rutgers University School of Public Health
10:05 AM
Nonparametric Tests for Transition Probabilities in Nonhomogeneous Markov Processes
Giorgos Bakoyannis, Indiana University
10:30 AM
Analyzing Semi-Competing Risks Data as a Longitudinal Bivariate Process
Sebastien A. Haneuse, Harvard T.H. Chan School of Public Health ; Daniel Nevo, University of Tel Aviv
10:55 AM
Endpoints and Treatment Effect Testing in Cancer Clinical Trials with Competing Risks
James Dignam, Dept of Public Health Sciences, University of Chicago
11:20 AM
Methods for Estimation and Inference of Cumulative Incidence with Missing Cause of Failure
Andrea Knezevic, Memorial Sloan Kettering Cancer Center ; Sujata M Patil, Memorial Sloan Kettering Cancer Center
11:45 AM
Floor Discussion
314 * !
Wed, 8/5/2020,
10:00 AM -
11:50 PM
Virtual
Statistical Advancements in Neurodegeneration Trial Designs and Analyses — Topic Contributed Papers
Section for Statistical Programmers and Analysts , Biopharmaceutical Section, Biometrics Section, Committee on Applied Statisticians
Organizer(s): Fanni Natanegara, Eli Lilly and Company
Chair(s): Fanni Natanegara, Eli Lilly and Company
10:05 AM
Impact of Model Misspecification on Alzheimer Trial Operating Characteristics
Saptarshi Chatterjee, Eli Lilly and Co ; Shrabanti Chowdhury, Icahn school of Medicine at Mount Sinai; Fanni Natanegara, Eli Lilly and Company
10:25 AM
Multivariate Endpoint, Disease Progress Model and Other New Features of the DIAN-TU Platform Trial
Guoqiao Wang, Washington University in St Louis ; Scott Berry, Berry Consultants; Chengjie Xiong, Washington University in St Louis; Jason Hassenstab, Washington University in St Louis; Melanie Quintana, Berry Consultants; Eric McDade, Washington University in St Louis; Paul Delmar, F. Hoffmann-La Roche Ltd; Matteo Vestrucci, University of Texas at Austin; Randall Bateman, Washington University in St Louis; Andrew Aschenbrenner, Washington University in St Louis
10:45 AM
TRCPAD: Accelerating Participant Recruitment in Alzheimer’s Disease Clinical Trials Using Machine Learning Techniques
Oliver Langford, University of Southern California ; Michael C Donohue, University of Southern California; Gustavo Jimenez-Maggiora, University of Southern California; Reisa Sperling, Harvard Medical School; Jeff Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health; Paul S Aisen, University of Southern California; Rema C Raman, University of Southern California
11:05 AM
Construction of Composite End Points to Better Align with Disease Progression and Improve Power
Samuel P Dickson, Pentara ; Suzanne B Hendrix, Pentara; Newman Knowlton, Pentara; Noel Ellison, Pentara
11:25 AM
Discussant: Richard Entsuah, Merck
11:45 AM
Floor Discussion
